Toward leaving no one behind: HIV infection among trans communities in Kazakhstan.

IF 8.4 2区 医学 Q1 PSYCHOLOGY, CLINICAL
International Journal of Transgender Health Pub Date : 2025-10-31 eCollection Date: 2026-01-01 DOI:10.1080/26895269.2025.2577163
Kelsey G Reeder, Yong Gun Lee, Jimin Sung, Vitaliy Vinogradov, Gulnara Zhakupova, Gaukhar Mergenova, Alissa Davis, Emily Allen Paine, Sholpan Primbetova, Assel Terlikbayeva, Sultana Kali, Timothy Hunt, Elwin Wu
{"title":"Toward leaving no one behind: HIV infection among trans communities in Kazakhstan.","authors":"Kelsey G Reeder, Yong Gun Lee, Jimin Sung, Vitaliy Vinogradov, Gulnara Zhakupova, Gaukhar Mergenova, Alissa Davis, Emily Allen Paine, Sholpan Primbetova, Assel Terlikbayeva, Sultana Kali, Timothy Hunt, Elwin Wu","doi":"10.1080/26895269.2025.2577163","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Central Asia, and Kazakhstan in particular, is virtually absent from global transgender (trans) Human Immunodeficiency Virus (HIV) research, despite evidence of disproportionate barriers to care. This absence erases local realities, weakens the evidence base, and renders communities invisible in policy. While global studies highlight trans people's heightened vulnerability to HIV and sexually transmitted infections (STIs) due to stigma, limited access, and scarce affirming services, little epidemiological data from Central Asia exists. This study addresses that absence by examining both known and newly detected infection prevalence among trans participants in Kazakhstan, underscoring the need to center trans health in the pursuit of collective trans liberation.</p><p><strong>Aims: </strong>Generate the first empirical data on HIV risk, prevention engagement, and structural determinants among trans people in Kazakhstan, situating findings within regional and global commitments to leaving no one behind in health.</p><p><strong>Methods: </strong>Analysis of HIV and STI prevalence among 68 trans participants in Almaty, Astana, and Shymkent (2018-2022), drawing on behavioral and biological data from a National Institute on Drug Abuse-funded prevention trial for substance-using cisgender (cis) and trans gay and bisexual men who have sex with men.</p><p><strong>Results: </strong>Most participants (69%) had tested for HIV at least once, 32% in the past six months; however, 37% did not know their current status. Fourteen (21%) were confirmed HIV-positive, 79% previously unaware. Nearly half tested positive for at least one STI, with 10% for multiple.</p><p><strong>Discussion: </strong>Findings reveal high HIV and STI burdens and critical gaps between self-reported awareness and confirmed diagnoses. Testing rates fall below UNAIDS 95-95-95 targets, highlighting the urgent need for expanded testing, research, and community-led interventions. Making these realities visible is essential for improving health in Kazakhstan and advancing collective trans liberation worldwide; without centering trans experiences, the global struggle for trans health and rights remains incomplete and the principle of leaving no one behind unfulfilled.</p>","PeriodicalId":48480,"journal":{"name":"International Journal of Transgender Health","volume":"27 5","pages":"2731-2739"},"PeriodicalIF":8.4000,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13618151/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Transgender Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/26895269.2025.2577163","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Central Asia, and Kazakhstan in particular, is virtually absent from global transgender (trans) Human Immunodeficiency Virus (HIV) research, despite evidence of disproportionate barriers to care. This absence erases local realities, weakens the evidence base, and renders communities invisible in policy. While global studies highlight trans people's heightened vulnerability to HIV and sexually transmitted infections (STIs) due to stigma, limited access, and scarce affirming services, little epidemiological data from Central Asia exists. This study addresses that absence by examining both known and newly detected infection prevalence among trans participants in Kazakhstan, underscoring the need to center trans health in the pursuit of collective trans liberation.

Aims: Generate the first empirical data on HIV risk, prevention engagement, and structural determinants among trans people in Kazakhstan, situating findings within regional and global commitments to leaving no one behind in health.

Methods: Analysis of HIV and STI prevalence among 68 trans participants in Almaty, Astana, and Shymkent (2018-2022), drawing on behavioral and biological data from a National Institute on Drug Abuse-funded prevention trial for substance-using cisgender (cis) and trans gay and bisexual men who have sex with men.

Results: Most participants (69%) had tested for HIV at least once, 32% in the past six months; however, 37% did not know their current status. Fourteen (21%) were confirmed HIV-positive, 79% previously unaware. Nearly half tested positive for at least one STI, with 10% for multiple.

Discussion: Findings reveal high HIV and STI burdens and critical gaps between self-reported awareness and confirmed diagnoses. Testing rates fall below UNAIDS 95-95-95 targets, highlighting the urgent need for expanded testing, research, and community-led interventions. Making these realities visible is essential for improving health in Kazakhstan and advancing collective trans liberation worldwide; without centering trans experiences, the global struggle for trans health and rights remains incomplete and the principle of leaving no one behind unfulfilled.

不让任何人掉队:哈萨克斯坦跨性别社区的艾滋病毒感染情况。
背景:中亚,特别是哈萨克斯坦,几乎没有参与全球跨性别(跨性别)人类免疫缺陷病毒(艾滋病毒)的研究,尽管有证据表明在护理方面存在不成比例的障碍。这种缺失抹杀了当地的现实,削弱了证据基础,使社区在政策中被忽视。虽然全球研究强调,由于污名化、获取途径有限和缺乏确认服务,跨性别者更容易感染艾滋病毒和性传播感染(STIs),但来自中亚的流行病学数据很少。本研究通过检查哈萨克斯坦跨性别参与者中已知和新发现的感染流行率来解决这一缺失,强调需要将跨性别健康作为追求跨性别集体解放的中心。目标:生成关于哈萨克斯坦跨性别者中艾滋病毒风险、预防参与和结构性决定因素的第一批经验数据,将调查结果置于不让任何人掉队的区域和全球承诺范围内。方法:分析阿拉木图、阿斯塔纳和奇姆肯特地区68名跨性别参与者(2018-2022年)的艾滋病毒和性传播感染流行情况,利用国家药物滥用研究所资助的一项针对使用药物的顺性(cis)、跨性别男同性恋和双性恋男性的预防试验的行为和生物学数据。结果:大多数参与者(69%)至少进行过一次艾滋病毒检测,32%在过去六个月内;然而,37%的人不知道自己的现状。14例(21%)被确认为艾滋病毒阳性,79%以前不知情。近一半的人至少有一种性传播感染检测呈阳性,10%的人有多种性传播感染。讨论:研究结果揭示了艾滋病毒和性传播感染的高负担以及自我报告的意识和确诊诊断之间的严重差距。检测率低于联合国艾滋病规划署95-95-95目标,突出表明迫切需要扩大检测、研究和社区主导的干预措施。让人们看到这些现实,对于改善哈萨克斯坦的健康状况和促进全世界的集体跨性别解放至关重要;如果不以跨性别者的经历为中心,争取跨性别者健康和权利的全球斗争仍然是不完整的,不让任何人掉队的原则也无法实现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.40
自引率
10.90%
发文量
27
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书